Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH2 | P05091 | 16/20 | 0.88 |
| ▸ | MAPT | P10636 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | MAOA | P21397 | 10/20 | 0.67 |
| ▸ | MAOB | P27338 | 10/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3591660 | 0.94 | ALDH2 (1.00) | ALDH2MAOAMAOB | |
| SCHEMBL12940403 | 0.93 | ALDH2 (0.81) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL810070 | 0.88 | ALDH2 (0.70) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL810041 | 0.87 | ALDH2 (0.72) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL809969 | 0.87 | ALDH2 (0.72) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL4095148 | 0.86 | MAPT (0.87) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL2107428 | 0.84 | ALDH2 (0.90) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL11421623 | 0.84 | ALDH1A1 (0.69) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL10623016 | 0.84 | ALDH1A1 (0.76) | ALDH2MAPTALDH1A1MAOAMAOB | |
| SCHEMBL810042 | 0.83 | ALDH2 (0.63) | ALDH2MAPTALDH1A1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802892-B2 | Functionalized phenolic compounds and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802147-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802892-B2 | Functionalized phenolic compounds and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-8802892-B2 | Functionalized phenolic compounds and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-20140099370-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC (US) | 2014-04-10 | — | — | US | disclosed |
| US-20130281652-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC | 2013-10-24 | — | — | US | disclosed |
| US-20130281652-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC | 2013-10-24 | — | — | US | disclosed |
| US-20130281652-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC | 2013-10-24 | — | — | US | disclosed |
| US-8217134-B2 | Controlled release of biologically active compounds | BEZWADA BIOMEDICAL, LLC (US) | 2012-07-10 | — | — | US | disclosed |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2009-07-02 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | BEZWADA BIOMEDICAL, LLC | 2009-03-05 | — | — | US | disclosed |
| EP-1951260-A2 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND ABSORBABLE THEREFROM | Bezwada Biomedical LLC (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007053794-A2 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND ABSORBABLE THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2007-05-10 | — | — | WO | disclosed |
| WO-2007053794-A2 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND ABSORBABLE THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090060979-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | ALDH2 1402/4885MAPT 4117/4885ALDH1A1 1816/4885 |
| US-20090170927-A1 | FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM | COMT, AOX1, UGT1A6 | ALDH2 1613/4885MAPT 2351/4885ALDH1A1 384/4885 |
| US-20140099370-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | GUSB, BMP2, APEH | ALDH2 1402/4885MAPT 4117/4885ALDH1A1 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.